Immunology
DTaP-IPV and DTaP-IPV/Hib
$10.00
Universal Activity Number: 407-000-10-011-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 03/01/2010
Expiration date: 03/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 03/01/2010
Expiration date: 03/01/2013
Article title:
view more on 407-000-10-011-H01-P
New Combination Vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel)
Golimumab
$10.00
Universal Activity Number: 407-000-10-008-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 01/01/2010
Expiration date: 01/01/2013
Article title:
view more on 407-000-10-008-H01-P
Golimumab: A Tumor Necrosis Factor Alpha Inhibitor for the Treatment of Rheumatoid Arthritis
Rotavirus Vaccines
$8.00
Universal Activity Number: 407-000-09-056-H01-P
CEUs 0.125
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 10/01/2009
Expiration date: 10/01/2012
CEUs 0.125
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 10/01/2009
Expiration date: 10/01/2012
Article title:
view more on 407-000-09-056-H01-P
Licensed Vaccines for Rotavirus Prevention in the US: A Review
Rotavirus Vaccines
$8.00
Universal Activity Number: 407-000-09-056-H01-T
CEUs 0.2
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 10/01/2009
Expiration date: 10/01/2012
CEUs 0.2
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 10/01/2009
Expiration date: 10/01/2012
Article title:
view more on 407-000-09-056-H01-T
Licensed Vaccines for Rotavirus Prevention in the US: A Review
Denosumab
$10.00
Universal Activity Number: 407-000-09-016-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 09/01/2009
Expiration date: 09/01/2012
Article title:
view more on 407-000-09-016-H01-P
Denosumab in Osteoporosis and Oncology